Navamedic's wholly owned subsidiary Vitaflo Scandinavia has signed a distribution agreement with Italian pharmaceutical company Angelini for the distribution of the drug Importal® in the Swedish and Dutch markets.
The available market for Importal® in these two countries is estimated at NOK 60 million. Importal® is used for treatment of several intestine disease related complications.
Navamedic's subsidiary Vitaflo Scandinavia is a distributor of more than 50 health care products from 17 manufacturers. The company saw a 32 per cent sales growth in the first nine months of 2011. Vitaflo will continue to expand its product base and increase sales.